Progenity, Inc. is a biotechnology company based in California that creates, develops and sells various molecular testing products within the United States. Their product line comprises targeted oral delivery of biotherapeutics, systemic oral delivery of biotherapeutics, and an ingestible smart capsule that not only identifies locations in the GI tract but also collects and preserves a sample for analysis. Key partnerships were formed with Ionis Pharmaceuticals for the OBDS and Recoverable Sampling System, predominantly for detecting and solving inflammatory-related issues and conditions such as ulcerative colitis and Type 2 diabetes.